457
Views
16
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Chronic Obstructive Pulmonary Disease in Stage I Non-small Cell Lung Cancer That Underwent Anatomic Resection: The Role of a Recurrence Promoter

, , , , , , , , & show all

References

  • Jemal A, Siegel R, Xu J, Cancer statistics, 2010. CA Cancer J Clin, 2010; 60: 277–300.
  • Hung JJ, Jeng WJ, Hsu WH, Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer. J Thorac Oncol 2012; 7:1115–1123.
  • Ost D, Goldberg J, Rolnitzky L, , Survival after surgery in stage IA and IB non-small cell lung cancer. Am J Respir Crit Care Med 2008; 177:516–523.
  • Ou SH, Zell JA, Ziogas A, Prognostic factors for survival of stage I nonsmall cell lung cancer patients: a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer 2007; 110:1532–1541.
  • Sawyer TE, Bonner JA, Gould PM, , Patients with stage I non-small cell lung carcinoma at postoperative risk for local recurrence, distant metastasis, and death: implications related to the design of clinical trials. Int J Radiat Oncol Biol Phys 1999; 45:315–321.
  • Varlotto JM, Recht A, Flickinger JC, Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer. Cancer 2009; 115:1059–1069.
  • Varlotto JM, Recht A, Flickinger JC, Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically resected, stage I nonsmall cell lung cancer. Cancer 2010; 116:2390–2400.
  • Nakajima T, Sekine Y, Yamada Y, Long-term surgical outcome in patients with lung cancer and coexisting severe COPD. Thorac Cardiovasc Surg 2009; 57:339–342.
  • Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357:539–545.
  • Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012; 21:309–322.
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646–674.
  • Gan WQ, Man SF, Senthilselvan A, Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59:574–580.
  • Lee KY, Ho SC, Chan SY, Reduced nuclear factor-kappaB repressing factor: a link toward systemic inflammation in COPD. Eur Respir J 2012; 40:863–873.
  • Walter RE, Wilk JB, Larson MG, Systemic inflammation and COPD: The Framingham Heart Study. Chest 2008; 133:19–25.
  • de Torres JP, Bastarrika G, Wisnivesky JP, Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 2007; 132:1932–1938.
  • Maldonado F, Bartholmai BJ, Swensen SJ, , Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest 2010; 138: 1295–1302.
  • Wilson DO, Weissfeld JL, Balkan A, , Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008; 178:738–744.
  • Li Y, Swensen SJ, Karabekmez LG, Effect of emphysema on lung cancer risk in smokers: a computed tomography-based assessment. Cancer Prev Res (Phila) 2011; 4:43–50.
  • Zulueta JJ, Wisnivesky JP, Henschke CI, Emphysema scores predict death from COPD and lung cancer. Chest 2012; 141:1216–1223.
  • Haqqani, A.S., J.K. Sandhu, and H.C. Birnboim, Expression of interleukin-8 promotes neutrophil infiltration and genetic instability in mutatect tumors. Neoplasia 2000; 2:561–568.
  • Takahashi H, Ogata H, Nishigaki R, , Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. Cancer Cell 2010; 17:89–97.
  • Mauri FA, Pinato DJ, Trivedi P, Isogeneic comparison of primary and metastatic lung cancer identifies CX3CR1 as a molecular determinant of site-specific metastatic diffusion. Oncol Rep 2012; 28:647–653.
  • Kaplan, R.N., R.D. Riba, S. Zacharoulis, , VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005; 438:820–827.
  • Egermann U, Jaeggi K, Habicht JM, Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients? Eur Respir J 2002; 19:464–468.
  • Mollberg NM, Ferguson NM. Postoperative surveillance for non-small cell lung cancer resected with curative intent: developing a patient-centered approach. Ann Thorac Surg 2013; 95:1112–1121.
  • Rubins J, Unger M, Colice GL. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest 2007; 132:355S–367S.
  • Butts CA, Ding K, Seymour L, Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. J Clin Oncol 2010; 28:29–34.
  • Strauss GM, Herndon JE 2nd, Maddaus MA, Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 2008; 26:5043–5051.
  • Hiratsuka S, Watanabe A, Aburatani H, Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 2006; 8:1369–1375.
  • Demicheli R, Fornili M, Ambrogi F, Recurrence dynamics for non-small-cell lung cancer: effect of surgery on the development of metastases. J Thorac Oncol 2012; 7:723–730.
  • Demicheli R, Retsky MW, Hrushesky WJ, Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures. Nat Clin Pract Oncol 2007; 4:699–710.
  • Mocellin S, Keilholz U, Rossi CR, Circulating tumor cells: the ‘leukemic phase’ of solid cancers. Trends Mol Med 2006; 12:130–139.
  • Tanaka F, Yoneda K, Kondo N, Circulating tumor cell as a diagnostic marker in primary lung cancer. Clin Cancer Res 2009; 15:6980–6986.
  • Rolle A, Gunzel R, Pachmann U, Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC(R) is a predictor for relapse: A preliminary report. World J Surg Oncol 2005; 3:18.
  • Hiratsuka S, Nakamura K, Iwai S, MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2002; 2:289–300.
  • Celli BR, Cote CG, Marin JM, The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005–1012.
  • Martinez FJ, Foster G, Curtis JL, Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173:1326–1334.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.